# Lincomycin

NDC: 25021-193
Generic name: Lincomycin Hydrochloride
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCONJUNCTIVAL
Marketing started: 20230415

FDA application: ANDA215657

## Active ingredients

- LINCOMYCIN HYDROCHLORIDE: 300 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-193"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-193
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75e149cc-b668-427e-bae7-a0d215e4fb7a
